About this trial
Interstitial lung diseases (ILD) are a group of chronic respiratory diseases that cause significant mortality and morbidity worldwide. Although there are studies in the literature comparing different lung disease groups with healthy individuals, it has been determined that there is no study comparing the exercise capacity, muscle oxygenation, physical activity level, respiratory functions, respiratory and peripheral muscle strength, inspiratory muscle endurance, quality of life and sleep quality of individuals diagnosed with ILD with healthy individuals.
Eligibility criteria
Qualifiers
Patients diagnosed with ILD according to ATS/ERS criteria,
Ages between 18 and 75,
Pulmonary infection during the previous month,
Participants who voluntarily participated in the study were included.
Disqualifiers
Acute pulmonary exacerbation or respiratory infection in the last four weeks
Obstructive lung disease
Systemic conditions affecting neurological, neuromuscular, orthopedic, or physical functions
Recent participation in a planned exercise program (within three months)
Trial design
Treatments tested in this trial
- Not listed